I 
113TH CONGRESS 
1ST SESSION H. R. 1285 
To amend the Controlled Substances Act to make any substance containing 
hydrocodone a schedule II drug. 
IN THE HOUSE OF REPRESENTATIVES 
MARCH 20, 2013 
Mr. BUCHANAN (for himself, Mr. MARKEY, Mrs. CAPITO, Mr. DIAZ-BALART, 
Mr. DUNCAN of Tennessee, Mr. MICA, Mr. ROE of Tennessee, Mr. ROG-
ERS of Kentucky, Mr. ROONEY, Ms. ROS-LEHTINEN, Ms. BROWN of Flor-
ida, Mr. COOPER, Ms. EDWARDS, Mr. HASTINGS of Florida, Mr. 
KEATING, Mr. LYNCH, Mr. RAHALL, Ms. WILSON of Florida, Mr. KEN-
NEDY, Mr. MURPHY
of Florida, Ms. CASTOR
of Florida, Mr. 
DESJARLAIS, Mr. FINCHER, Mr. MILLER of Florida, Mr. NUGENT, Mr. 
TIBERI, Mr. ISSA, Mr. DEUTCH, Mr. POSEY, Mrs. BLACK, Mr. PEARCE, 
Mr. MARINO, Ms. SLAUGHTER, Mr. WESTMORELAND, Mr. STIVERS, Mr. 
BENISHEK, 
Mr. 
CRENSHAW, 
Mr. 
ROSS, 
Mr. 
HIGGINS, 
Mr. 
SOUTHERLAND, Mr. TIPTON, Mr. SHUSTER, Mrs. MILLER of Michigan, 
Mr. RODNEY DAVIS of Illinois, and Mr. SCHOCK) introduced the following 
bill; which was referred to the Committee on Energy and Commerce, and 
in addition to the Committee on the Judiciary, for a period to be subse-
quently determined by the Speaker, in each case for consideration of such 
provisions as fall within the jurisdiction of the committee concerned 
A BILL 
To amend the Controlled Substances Act to make any 
substance containing hydrocodone a schedule II drug. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
VerDate Mar 15 2010 
02:00 Mar 26, 2013
Jkt 029200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H1285.IH
H1285
pwalker on DSK7TPTVN1PROD with BILLS
SECTION 1. HYDROCODONE AMENDMENT. 
(a) IN GENERAL.—Schedule III(d) in section 202 of 
the Controlled Substances Act (21 U.S.C. 812) is amend-
ed by— 
(1) striking paragraphs (3) and (4); and 
(2) redesignating paragraphs (5), (6), (7), and 
(8) as paragraphs (3), (4), (5), and (6), respectively. 
(b) EFFECTIVE DATE.—The amendments made by 
subsection (a) shall take effect on the date that is 6 
months after the date of enactment of this Act. 
SEC. 2. PHYSICAL SECURITY REQUIREMENTS. 
Notwithstanding the amendments made by section 1, 
the Attorney General shall immediately, without regard to 
chapter 5 of title 5, United States Code, amend section 
1301.72 of title 21, Code of Federal Regulations, relating 
to the physical security controls for non-practitioners, nar-
cotic treatment programs and compounders for narcotic 
treatment programs, and storage areas for controlled sub-
stances, to allow, for the 3-year period beginning on the 
date of enactment of this Act, manufacturers and distribu-
tors to store hydrocodone compound products in accord-
ance with the physical security requirements for schedule 
III, IV, and V controlled substances. 
SEC. 3. GAO REPORT. 
(a) IN GENERAL.—Not later than 18 months after 
the date of enactment of this Act, the Comptroller General 
VerDate Mar 15 2010 
02:00 Mar 26, 2013
Jkt 029200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H1285.IH
H1285
pwalker on DSK7TPTVN1PROD with BILLS
of the United States shall submit to Congress a report 
on the reclassification of hydrocodone products under this 
Act. 
(b) CONTENTS.—The report required under sub-
section (a) shall include— 
(1) an assessment of the degree to which the 
reclassification of hydrocodone products under this 
Act impacts the ability of patients with legitimate 
medical needs, particularly those in rural areas and 
nursing home facilities, to access adequate pain 
management; and 
(2) recommendations necessary to address 
issues, if any, relating to patient access to adequate 
pain management. 
Æ 
VerDate Mar 15 2010 
02:00 Mar 26, 2013
Jkt 029200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6301
E:\BILLS\H1285.IH
H1285
pwalker on DSK7TPTVN1PROD with BILLS